Gerresheimer, DE000A0LD6E6

Gerresheimer stock ends the day without a U.S. close

Published on 09/23/2026 at 23:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 23, 2026, Gerresheimer stock had no substantiated U.S.-dollar closing quote from an NYSE, Nasdaq or clearly identified OTC venue in the available market data.

Automatisierte Glasampullen-Produktionslinie in steriler Pharmafabrik
Gerresheimer AG mit ISIN DE000A0LD6E6 produziert Glasampullen in hochautomatisierter, steriler Pharmaverpackungsfertigung mit modernster Anlagentechnik, Illustration mit AI erstellt.

Gerresheimer stock did not have a substantiated U.S.-dollar regular-session close for September 23, 2026, on an identified NYSE, Nasdaq or OTC venue. The available dated quotation concerned the Xetra-listed security rather than a U.S.-listed share, so it does not establish the U.S. market close.

September 23, 2026 session data

Gerresheimer AG (ISIN DE000A0LD6E6) was reported at USD data unavailable for a U.S. venue, while the dated Xetra reference in the available report was from September 21, 2026. That report stated a 0.4 percent decline to the Xetra close and identified the security as trading under ticker GXI on Xetra, but its foreign-currency share price is not used here.

The S&P 500 was reported at 7,713.92, down 0.65 percent on September 23, 2026, while the Nasdaq was reported at 27,244.28, up 0.5 percent. These index figures provide U.S. market context but do not substitute for a U.S. quote for Gerresheimer.

September 24, 2026 outlook

Gerresheimer's available event information listed publication of its half-year financial statements for September or October 2026, without establishing a September 24 release. The next U.S. trading session is September 24, 2026, and the available evidence does not provide a substantiated U.S. after-hours price or a company-specific event for that session.

Disclaimer...

en | DE000A0LD6E6 | GERRESHEIMER | boerse | 70170846 | bgmi